ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000457.1|Vicibactin_1 # 1 # 720 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.665	BGC0000457.1|Vicibactin_1 	1	720	+	Loose	550	27.7202	OXA-308	25.37	3001763	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCAGCAATCAGACAACCAGCCGGCCGCCATCGATGTCGTGCTCTGGCAATATCCGCAGAACGGAAGCGATGGGGAGCGCTGGATACGGTCGCTGTCCTCGAATGAGCGAGAGCGCGCCGCGACCTATCGCTTCGAACGCGACCGGACCTCGTTCATCGCCGGCCGCTATCTGCTGCGGCAAGTGCTGAGCGCGCATACCGAAACGCGGCCTGACAAGGTCGTGTTGCTGGCGGATGCGCACGGCAAGCTGGCGGTCGAGGGCGGCGACACGCTGCAGTTCAGCCTTTCCAATGCCGACGGGCTGGTGGCGGTCGCCGTCGCTTCGGAATGCGCGCGCGTCGGGATCGACTGTGAACGCGCTGATGCCGAGGTCGAAGCGGCGGCGGTGGAGAGCTATTGCAGTCCGGACGAACGGCGGTGGCTCGATCAAGTGCCTGCGGGCGAACGGCCGCGTGCGGCCGTTGCCCTTTGGACGCTGAAGGAGAGCCATCTCAAGGCGCTCGGGGTGGGCTTGCGCGGGGATGCCCGCAGCGTCGCCTTTTCCTGGCAGGACGGCATCCCCGTTCTGGTTCACAGCGGCGAACCGGACCGGCAATGGCATCACCGCCTGGTCGAGAGCGGCAGCCAGCACGTCGTCGCACTGGCCGCCCGCTCATCATCCGCCGCGCCCGGCATTCATGTCCTGACGTTTCAGGACGAGAGCATGCCGTCCCCATAG	MQQSDNQPAAIDVVLWQYPQNGSDGERWIRSLSSNERERAATYRFERDRTSFIAGRYLLRQVLSAHTETRPDKVVLLADAHGKLAVEGGDTLQFSLSNADGLVAVAVASECARVGIDCERADAEVEAAAVESYCSPDERRWLDQVPAGERPRAAVALWTLKESHLKALGVGLRGDARSVAFSWQDGIPVLVHSGEPDRQWHHRLVESGSQHVVALAARSSSAAPGIHVLTFQDESMPSP	MNKKLNLALLCFLSILCAACQSNQQLSANSHTENHNTRAAEISLLFDEMHTQAVFVTYDGQHFQSYGNALQRADTAYVPASTFKMLNALIGLQNHKATNTEVFKWDGQKRAMSIWEKDMTLSDAMKVSAVPVYQELARRIGLDLMQKEVTRVRYGNTDIGTVVDRFWLDGPLKITPKQEAQFAYQLATQQLPFDQNVQSQVKDMLYVESRGQSKLFAKSGLSMKNGQPDIGWYTGWVEQADGKIVAFSINMQMVQGLDVNSRQQATLDILDKLGIFFYL	85.66	gnl|BL_ORD_ID|2562|hsp_num:0	3470			357	744	cloxacillin; oxacillin; cefalotin
BGC0000457.1|Vicibactin_2 # 693 # 2051 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.627	BGC0000457.1|Vicibactin_2 	693	2051	-	Loose	600	28.1054	APH(9)-Ia	32.43	3002662	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(9)	ATGACCGTCGCTTTTACCCGCAGGGATGCCCTCAACGAGCCGCTCGATCTTGCCGGCATCGGCATCGGTCCCTCCAATCTGAGCCTTGCCTGCCTGCTGGAATCCGTGCCCGAAGTGCGCAGCCGCTTCTTCGAGCGGCGAGCCTCGTTCGACTGGCATCCCGGCATGATGATGCCCGGGGTCGAGCTGCAATCATCCTTCCTGAAGGACCTCGTCACGCCGGTCCTGCCGACGAGCCGCTGGTCGTTCGTCTCCTATCTGGTGGCGCATAAGCGGCTCTACGCCTTCCTGAACGCCAATTACGAGGCCGTTCCCCGGCAGGAATTTGCGCGCTATCTCGCCTGGGTCGCCAATGGCGTTGACGGCTTGCGCTACGCAACTGAAATTCGCGACGTGGAGCACCGCGACGACCGTTTCGTCCTGCGCTTCGACAACGGCCAGGAAGAAGCGACGAATCTGGTGATCGGTACGGGGTCTTCGCCCTTCGTGCCCGACTGGGCGAAACCCTTCCTTGGGCCCGATTGCTTCCACAACAGCGATGCCAAGTCGCGTCTCAAGGATCTTCGCGCCGGCCGCATCGTCGTGGTCGGCGGCGGCCAGAGCGGCGGCGAGGTGGTCGACGCGCTGCTTGGGGATGCCAGCTCGATCAAGGAGCTGACCTGGATCAGCCGGCGCCACAATTTCGAGCCGATCAACGACACGCCGTTTTCGAACCAGGTCTTCTCGCCGGAATATGTGCAGGCCTATCTGAAGCTCAGCGGCGAGCAGAAACAGGCGGCGCTGAAGAACTCGATCCTGACCAGCGACGGCCTGTCGATCTCGACGATCCACTCGATCTACCGACGCCTCTACGCGCTGCGGTATCTCGATCAGAGCACGCTGAACGCATCTCTGTCGCCGAACCGCGACGTGATCCAGATGGAGCGGAACGGCAATGCCTATCGGCTGATCGTCCGCAACCATTTCGACGGCGGGATCGAGGTGCTGCATGCCGATGCGGTGGTGCTGGCCACCGGCTACAGGTTCCGTTTGCCGGATGCGCTCGGTTCGCTCGGCGAAAGGATCAGCCTCGACAGAAATGGATATCCCACCTTGAACGACGACTACACGATGCAGTGGACAGGCCCGAGGTCCAACCGGCTGTTTGCCCAGAATGCCGGCCGATACTCGCACGGCATCGCCGACTCGCAGCTCAGTCTCATGGCCTGGCGCAGCGCCAAGATCGTCAACACGATTCTCGGCCGGCAGCATTTCGATGCCGAACCCGACAATGCGCAGCTGGTCTGGGCGACGGAGGCAGCTTCCGCCATGCCGCATCAGCTCCGGGTCGGCTATGGGGACGGCATGCTCTCGTCCTGA	MTVAFTRRDALNEPLDLAGIGIGPSNLSLACLLESVPEVRSRFFERRASFDWHPGMMMPGVELQSSFLKDLVTPVLPTSRWSFVSYLVAHKRLYAFLNANYEAVPRQEFARYLAWVANGVDGLRYATEIRDVEHRDDRFVLRFDNGQEEATNLVIGTGSSPFVPDWAKPFLGPDCFHNSDAKSRLKDLRAGRIVVVGGGQSGGEVVDALLGDASSIKELTWISRRHNFEPINDTPFSNQVFSPEYVQAYLKLSGEQKQAALKNSILTSDGLSISTIHSIYRRLYALRYLDQSTLNASLSPNRDVIQMERNGNAYRLIVRNHFDGGIEVLHADAVVLATGYRFRLPDALGSLGERISLDRNGYPTLNDDYTMQWTGPRSNRLFAQNAGRYSHGIADSQLSLMAWRSAKIVNTILGRQHFDAEPDNAQLVWATEAASAMPHQLRVGYGDGMLSS	MLKQPIQAQQLIELLKVHYGIDIHTAQFIQGGADTNAFAYQADSESKSYFIKLKYGYHDEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNGFTQNLTGKQWKQLGKVLRQIHETSVPISIQQQLRKEIYSPKWREIVRSFYNQIEFDNSDDKLTAAFKSFFNQNSAAIHRLVDTSEKLSKKIQPDLDKYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAPKERDLMFIGGGVGNVWNKPHEIQYFYEGYGEINVDKTILSYYRHERIVEDIAVYGQDLLSRNQNNQSRLESFKYFKEMFDPNNVVEIAFATEQ	136.56	gnl|BL_ORD_ID|227|hsp_num:0	252			609	714	spectinomycin
BGC0000457.1|Vicibactin_3 # 2048 # 6040 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.647	BGC0000457.1|Vicibactin_3 	2048	6040	-	Loose	1000	112.849	almE	25.21	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGAACAAGCAGATCACCAATTTCGCCGATGCCCGTCCGACCGACGCAGTGGACGCCGTCTTCGAGAGCTTTCCGCTGACCATCGCGCAGAAGCGCATCTGGTCGCTGGAGCAGATCGGCAATTACACGGTCTTTCCCGCTCAGGTCATAGGGCTGCGGCTGAGCGCCGCGATCGACGTCGAGACGATTGCCGGCGCCTGCCGCGCGCTCGTGGCGCAGAATCCATCGCTTGCCTTCCGCTTCCGCCGGCTGGCGGGCGGCCGCATCGAGCAATATCGCGGCGCGTCGAGCGAAGTGCCGCTCGATATCCTCGGCAAGGACGGCGCGGCTCTTTCCGAGCCCGATGCCTTGGCCGCACGGAAAGCCTTCCGCGACAAGCGCTTCGATCTCCTGGAAGGGCCAGGCGCACGCATCCAGATCATCCGGCTTGCCGATGGGCAGTCGCTGCTGACGATCATGCTGCATCCGATCATCTGCGACGACCGCGAAAAATCCGTTCTTGCCGGGTCGCTGGCCAGCATTCTCGATGGCGAACCCGCCGGCGATATGCAGCCGGTGGAAATCGCCGCCGGGGCGCGCGAGGCCGATTGGCTGGAGACGGATGAGGCGCGGCAGGCGCTTGCCTACTGGCGCGATGCGATAGGTTTGGACTATGCGGCCTCGACCTTCCCGACCCGTTTCAACAGCGGTGGGCTGGCAGGCGTGGCGCGCGCCGAGCATCGGTTTTCGATCGCCCCCGAGCTCTGGAGCAAACTCGAACGGCATGCGAGGGGGAAGGGCGTTCACGTCGAGCGCGTGCTTCACGCCGCCTTCTGCGCGCTTCTGGCGCGCTACAACGGCAACTATGCCCTGCTGACCGGCCTGCTTGTCGCGCGGCCCCGCACCGAACATCTCGCCAGCCGCGGCCGCGCCGAGCAGGTTCTTCCCCTTGTGCTCTCGCTGACCTCGAGACACTCGCTCGACGATGTCGTCGCGGCGATCTCGTCGGTGACGCAGGAGGGGCTTGCCCGCCTCGTGCCGCTGGAGCGCATCACGCAGGAACTTGTTGTCGACGAGGCAGCCGCCCAGGAGGCCGTGGTCAAGGCCTTGTTCGAATTCCGCGAACCTTATCCCGTCCCGAGGCAGGCGACGAACCTGGAACCCTCAGGCGCACGCGCCGACAGCGAGCTCTCCCTAGTCGTCGAGGCTCGCACGGATGGCGGCGCGTACGGGCTGATCGACTATGCCGGCGATCTCTATGACGACGCCCTGATTGCCCGTGTCTCCAGGCATTATTGCCTGGTGCTGGAGCAGATCGTCGCCAAGCCCGATCTCAGGATCAGGGATATCGAACTCATGGGCAGCGACGAGCTCGACTGGCTGTCGGCGCCCTATGAGGATGACGCCGTCAATGACGACCGGCCGGTGCACGAGCTGATCTCGGCCCATTCGCGCCGCACGCCAGACAAGACCGCGATCGTCTATGGCGACGAGGAGTGGAGCCATGGCTGGCTGGAGGCGAGCACCAACCGCCTCGGTCATCGGCTGCGGCAACTCGGCGTTCGCGCCGAAGTGACGGTCGCAATCTTCATCAAGCGCTCGCCGGAGGCGATCGTCGGCATCCTCGCGACCTTGAAGGCCGGCGGCGCCTATATTCCCGTTGAGCCTGACCATCCGCCGGTGCGCAACCACCACATCCTGCGCGATGGCGGCGTCAAGATCGTGCTCACCCATAGCTGGCTGCGCCACCGCCTGCCGGAAGAACTCGACGCGACCGTCCTCGAACTCGACAAGCTCGATCTCGAGGGCGAGCCGGATACGCCGCTTTATGTTCCCACGCACAAGGACCAGCTCGCCTATGTCATGTACACCTCGGGCTCGACGGGATTGCCGAAAGGCGTCGCCGTCGAGCACGGGCCGCTGACGCACCATCTGCAGAATACCTCGCGCGTCTATGGCATGAGCTCGGAATCCCGCGAGCTGCCCTTCCTGCCCTTCAGTTCGGATGGCGGCCATGAGCGGTGGATGAACCCGCTGATGGAAGGCGGCAGCATCATTCTTCCCGACCAGCCGCTCTGGACGCCTGAGGAGACGCTGACGGCGATGCGCAAGCATGGCGCCAACAATGCGAGCATTCCCACAACCTATCTGCAGCAGCTGGCGGAATGGGCCGATAGCACTGACAGCGCGCCGCCGATGCGGCTCTATTCCTTTGGCGGCGAGGGGCTGGCGCAAACGACCTTCGATCTTCTGTCGCGGGCGCTGAAGTCGGAATGGCTGATCAACGGCTATGGTCCCACGGAAACGATCATGACGCCGATGGTCTGGAAGGTCAGGGCCGGCACGAAGTTCCAGGGCGTCTATGCGCCGCTCGGCCGCGCGGTCGGGCTGCGGCGCGTCTATGTGCTCGATCCCGATCTCAACCTGTGCCCGATCGGCGTGACCGGCGAACTCTATATTGGCGGCGAGGGCATCGCGCGCGGCTATCTCGGCAAAGCAGATGCGACCGCCGACCGTTTCATCCCCGACCCATTTTCCAAGAAGGGCGGCCGGCTCTATCGCTCCGGCGACCTGACACGTTGGCGCGAGGACGGAACGGTCGAATTCGTCGGCCGCGTCGATCATCAGGTGAAGCTGCGGGGATACCGCATCGAACTCGGCGAGGTCGAAGCCGCACTCCTCCAGCAGCCCGGCGTCGGCGAAGCCCTGGTCGTTCTGCGCGATGACGATGCCGGCGGCGAAAAGGCGCTGGTCGCCTATGTCGTGCCGAAGAAGGATGAGAGGCTTGACGTCGAGACGGTGCGCGCCGGCCTCGAGCGCAGCCTGCCATCCTATATGGTGCCGGCGGCCGTGGTCGAACTCGAGAAGATGCCGACCAATCCGAACAGCAAGCTCGACCGCTTCGCGCTGCCCGCACCCCAGCCGGTCAAACGCGCAATCATCGAGCCGGCGACCGCGCTCGAAGAGGAGGTGCTGGATGTCTGGCGCCGGGTTCTCAAGCTGGAAGCGATCAGCGTCGAGGATAATTTCTTTGCCATCGGCGGCAATTCGCTGGGCGCGATCCGCATCCTCACGCAGCTCAGGCAGCGCCGGCCGAAGATCCCGCTCACCGTCGCCGATATCTTCAACAACCCGACCATTCGCGCCTTTGCCGGCGTGATGGAGCAGGGGGAGGAGCGCGATCTCTCCGAGGTGATCGTGCTGCGCGCCTCCGGCGCCAAGCCGCGGCTCTATTGCTTCCCGGGGCTCCTCGTCAGCACCCGCGAATATGTGAAGCTCGTCGATTATCTCGGCGCCGATCAGCCGGCGACCGGCTTCATTTGCCACTCGCTGTCCGAGAAGAAGGAAGTCGGGGCGCCTGTTGAAGAGATCATCGAGAGCTATGTCGACTATATCAGGAAGCACAGCGGCGGCGCGCCCTGCACTTTCCTCGGTTGGTCCTGGGGCGGGCTCCTGGCTTACGAGGCCGCCCGCACCCTTGCTAACGAGGTCGACGTCAGGATGATGGCGATGGTCGATGTCTGCGACCTCGGATCGGAATTTGCCATCGGCGCCAAGCCGAGGTTCCGGCCCGGCGAACGCGACATGCTGCACCGGGACGTGCAGGCATGGCTGCAAAAGACGGCGATGCGGCCCGAATCGGACCGGCTGCTGTCGACGATGGACGCCGATACCTACGAGCAGTTCCTGCGCTTCGTCGGCGACGAGAAGGATCCGCTTCCCACAGACGGGCCCGACATCAGCAGCCGCGAGCATACGTTCTGGGTGCTGATCGACAACGCCCTGATCTTCCGCAAGCACCGGCTCGTTCCCCATGACGTGCCGATCTATCCCTGGGCGGCCGATGACAGCCTCAACCGCGGCCTCAACCTGATCGATTGGCGCCGCCTGTCGCCGCGGGCTCGCGCGGCCGAAATCATCACCGGCACCAACCATCTGCACATGATCGGGTCTCCCGCCTTCCATTCAAGGCTTGCCCTGCGTCTCAAGGAAACAGAGAAGGATAACGCATGA	MNKQITNFADARPTDAVDAVFESFPLTIAQKRIWSLEQIGNYTVFPAQVIGLRLSAAIDVETIAGACRALVAQNPSLAFRFRRLAGGRIEQYRGASSEVPLDILGKDGAALSEPDALAARKAFRDKRFDLLEGPGARIQIIRLADGQSLLTIMLHPIICDDREKSVLAGSLASILDGEPAGDMQPVEIAAGAREADWLETDEARQALAYWRDAIGLDYAASTFPTRFNSGGLAGVARAEHRFSIAPELWSKLERHARGKGVHVERVLHAAFCALLARYNGNYALLTGLLVARPRTEHLASRGRAEQVLPLVLSLTSRHSLDDVVAAISSVTQEGLARLVPLERITQELVVDEAAAQEAVVKALFEFREPYPVPRQATNLEPSGARADSELSLVVEARTDGGAYGLIDYAGDLYDDALIARVSRHYCLVLEQIVAKPDLRIRDIELMGSDELDWLSAPYEDDAVNDDRPVHELISAHSRRTPDKTAIVYGDEEWSHGWLEASTNRLGHRLRQLGVRAEVTVAIFIKRSPEAIVGILATLKAGGAYIPVEPDHPPVRNHHILRDGGVKIVLTHSWLRHRLPEELDATVLELDKLDLEGEPDTPLYVPTHKDQLAYVMYTSGSTGLPKGVAVEHGPLTHHLQNTSRVYGMSSESRELPFLPFSSDGGHERWMNPLMEGGSIILPDQPLWTPEETLTAMRKHGANNASIPTTYLQQLAEWADSTDSAPPMRLYSFGGEGLAQTTFDLLSRALKSEWLINGYGPTETIMTPMVWKVRAGTKFQGVYAPLGRAVGLRRVYVLDPDLNLCPIGVTGELYIGGEGIARGYLGKADATADRFIPDPFSKKGGRLYRSGDLTRWREDGTVEFVGRVDHQVKLRGYRIELGEVEAALLQQPGVGEALVVLRDDDAGGEKALVAYVVPKKDERLDVETVRAGLERSLPSYMVPAAVVELEKMPTNPNSKLDRFALPAPQPVKRAIIEPATALEEEVLDVWRRVLKLEAISVEDNFFAIGGNSLGAIRILTQLRQRRPKIPLTVADIFNNPTIRAFAGVMEQGEERDLSEVIVLRASGAKPRLYCFPGLLVSTREYVKLVDYLGADQPATGFICHSLSEKKEVGAPVEEIIESYVDYIRKHSGGAPCTFLGWSWGGLLAYEAARTLANEVDVRMMAMVDVCDLGSEFAIGAKPRFRPGERDMLHRDVQAWLQKTAMRPESDRLLSTMDADTYEQFLRFVGDEKDPLPTDGPDISSREHTFWVLIDNALIFRKHRLVPHDVPIYPWAADDSLNRGLNLIDWRRLSPRARAAEIITGTNHLHMIGSPAFHSRLALRLKETEKDNA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	239.21	gnl|BL_ORD_ID|4935|hsp_num:0	5928			237	1629	colistin A; colistin B
BGC0000457.1|Vicibactin_4 # 6059 # 6277 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.658	BGC0000457.1|Vicibactin_4 	6059	6277	-	Loose	550	22.7126	KPC-77	62.5	3006202	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; penam	antibiotic inactivation	KPC beta-lactamase	ATGGACAATCTTGAGCCCCGCGACGATCTCTGGATCGTCGTCATTGACACCGAGCACCACTACTCGGTCTGGCCGCAGGACAAGCGGATTCCGGTGAGCTGGAAGGCCGCGGGCTTTGCCGGTTCGCGCCAGGAATGCCTGGCCCATATCCGCGACGTGTGGACCGATCCCCGCCCGCTCTCCCTGCGCTCGGCGATGGCCGGCGATGCGCGTCTCTGA	MDNLEPRDDLWIVVIDTEHHYSVWPQDKRIPVSWKAAGFAGSRQECLAHIRDVWTDPRPLSLRSAMAGDARL	MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRAEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAELSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDPWELELNSAIPGDARDTSSPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVYGTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ	24.57	gnl|BL_ORD_ID|3667|hsp_num:0	4736			483	531	
BGC0000457.1|Vicibactin_5 # 6430 # 7458 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.623	BGC0000457.1|Vicibactin_5 	6430	7458	+	Loose	275	61.2326	AAC(6')-IIc	27.91	3002596	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGCTCGCAGCGTCAAATGTCTTGCCGATCAAGGAGAACATCATGGATTTCGATGCCGCCAGACAGAGGCGGGCTCTGCAGTCGCGGAGCTACATCAGGCTCGCCCCCAACATCGTCCACCTGAAGACCGCGCATGGACAGCACGAAGCCGCCTTCGAGGCCGAGGCCGGCGTCGCAACGATCGCCTTCTACCACGGCGAGCCGCCGCAATCGGCGGAGCTTCTGATGGCGGCGGCCGAAGCGGTGACGGCGGAGGATCGCTCGATCAAGTCGGTCGTCTTCGAAGGCCATCAGGCAGGCCTTCCCCATCATATTTCAAGCACGGGGAAGCTCGATTCCGCGGTCCTCTGGCAATGGCCGTCGCTGTGGCTGCCGCAGCTGACCTATCCGCTGCCGCCGGTACGCGAGATGACCGCCGGCCGCTATCATCCGCGCCGGCCGGCAAAGCCGAAGGGCACCGTCTACCAGCGTTTCATTCCCTGGCTGGAGCGGGACATCAGCTTCCGCGTGGTCGATCCCGAGACCGATCTTGCGGCCTTCCACCGCTGGATGAACGATGAACAGGTCAACACGATCTGGGAGGATTCGGGCTCGATCGAGAAACACCGCGAGATCCTGGAGGAGCGGATCGCCGATCCGCATGTGCTGCCGCTGATCGGCAGTTTCGCCGATATCCCCTTCGGCTATTTCGAAGTCTATTGGGCCAAGGAGAACCGGCTCGGTCCCTTCTACGATGCCGATGATTACGATCGCGGCTGGCATGTGGCGATCGGTGAGCCGGATCATCGCGGAAAAAAATGGATCAGCGCCTGGCTTCCCTCGCTGATGCATTTCATCTTCCTCGACGATCCCCGCACGCAGCGCATCGTCGGCGAGCCGCGCGCCAGCCACGAGCAGCAGATCCGCAATCTCGACCGCTCGGGCTTCGCCAAGGTCAAGCATTTCGATTTTCCGCATAAGCGGGCGCTGCTCGTGATGCTGAGCCGCGAGCGTTTCTTCGGCGATCATCTCTGGGTGCCGGCATCATGA	MLAASNVLPIKENIMDFDAARQRRALQSRSYIRLAPNIVHLKTAHGQHEAAFEAEAGVATIAFYHGEPPQSAELLMAAAEAVTAEDRSIKSVVFEGHQAGLPHHISSTGKLDSAVLWQWPSLWLPQLTYPLPPVREMTAGRYHPRRPAKPKGTVYQRFIPWLERDISFRVVDPETDLAAFHRWMNDEQVNTIWEDSGSIEKHREILEERIADPHVLPLIGSFADIPFGYFEVYWAKENRLGPFYDADDYDRGWHVAIGEPDHRGKKWISAWLPSLMHFIFLDDPRTQRIVGEPRASHEQQIRNLDRSGFAKVKHFDFPHKRALLVMLSRERFFGDHLWVPAS	MSANNAAIVLRVMAENDLPMLHAWLNRPHIVEWWGGEDERPTLDEVLEHYSPEVLAKQAVVPYIAMLDDEPIGYAQSYIALGSGDGWWEDETDPGVRGIDQSLANPSQLNKGLGTKLVRSLVELLFSDPAVTKIQTDPSPSNHRAIRCYEKAGFVQEKNILTPDGPAVYMVQTRQAFESLRTVQSFKIKGKWS	177.20	gnl|BL_ORD_ID|674|hsp_num:0	730			21	531	dibekacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin; gentamicin
BGC0000457.1|Vicibactin_6 # 7455 # 8873 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.651	BGC0000457.1|Vicibactin_6 	7455	8873	+	Loose	850	127.872	mepA	26.53	3000026	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	ATGAACGACATGAGCGAGATGAGCGGCAGCCTGCGGAAAGGGCGGCTTGCGCCGGAAGATCTTGCCAGCCCGCACCTTTTCAGGCTGCTGCTGCGGCTCGGGCTGCCCGCCATGTTCGGCCTGTCGATCAACGCCGCCCACCACACGATCAACATGATCTTCGTCGGCATGATCGGCGAAGACCAGATCGCCGCGATCATGATCGTGCTGCCGGTCCTGATGCTCGTCGCCGCTTTCGGCGAAGGCATCGGCGTCGGTGTGGCGACCGAGGTCGGGCGCGCACTCGGCGCCGGCAACCGGTCGAGAGCCAGCACCCTTGCCTCGGTCAGCCTTGCCGCCGGCGTCGCCTTCGGCGCCGCAAGCGCGGTTGCGATCGCAGCCTTTCCCTCGGTTCTGCTGTTCGGCGCCACATCAGCGATCGAGCCGCTGGCACAGCATTATCTCCTCGTCATCGTGGTCTCGATTCCACTGACGATGGCGCAGATCATTCTCGACTTTCTGGCAATAGCCGAGGGCAATGCCCGCTTCAGCATGTGGACGCTCGTCGCCTGCTTCGCGCTGAACATCATCCTCGACCCGATCATGATCTTTGGCTTCGGTCTCGGCCTGCAGGGCGCGGCGATGGCAACCATCCTCTCCCAGCTCGTGGCGCTCTCGATCTACGGCGCCTATCATGCGAGGCGGCTTGGGACGATCCGACTGACGTTCGGCTGGCCATTCGGCGACCTCAGGCATCTCAAGGCGGTCCTTGCTGTGGGCGCACCGACGACGCTGACGAGCCTCGCGACGGCGGGCGCAATCGCTGCGATGCTGTCGGTCGCCGGCACCTATCACGGTGAAGACGGCATCGCCGGCGTCGGCATCGCCTTGCGGCTGCTTGCGGTCGGCGCTTTGCCGGTCATCGGCATTTCGCTCGGGGCGCAGTCCATCCTGAGCTTTGCCTGGGGGCGCGGGGATATCTCCCGGGTGCTGGCGGCAGCCCGCATGCTCTCAGTTGTCACGAGCGCGGTCGGCGGCGTCTACGGGCTGGCAGCGATCATCTTTTCCGAGCGTCTTGCCGCGTTTTTCACCGACGAAGCTTCCGTGCTTTCGATCGCCGGCCAGGCGATCGTCGCAACCCATCTTCCCTTCCTGCTGTTCGGCCTCCGGCAGACCGTGCTGATCCTCTTCCAGGCGCAGGGCAGGCCGAACGCCGCCCTTGCCGTCGGCCTGGCGCAGAACGGATATCTTCTCTTTCCGCTGCTTGCGCTGCTGCCGCCCTTCTTCGGATTCTCCGGCCTGCTCTGGGCCATGTTCCTGGCTTCGGCGCTCACTGGCCTGTTGTCATGCTTCTGCCTCGCCCGATCCCTCGGCGCGCTCCGGCAGCGCTCGGACGAACCTCTGACATCAATCCGTCCCTATCCCCGCTTTTGTCCATGA	MNDMSEMSGSLRKGRLAPEDLASPHLFRLLLRLGLPAMFGLSINAAHHTINMIFVGMIGEDQIAAIMIVLPVLMLVAAFGEGIGVGVATEVGRALGAGNRSRASTLASVSLAAGVAFGAASAVAIAAFPSVLLFGATSAIEPLAQHYLLVIVVSIPLTMAQIILDFLAIAEGNARFSMWTLVACFALNIILDPIMIFGFGLGLQGAAMATILSQLVALSIYGAYHARRLGTIRLTFGWPFGDLRHLKAVLAVGAPTTLTSLATAGAIAAMLSVAGTYHGEDGIAGVGIALRLLAVGALPVIGISLGAQSILSFAWGRGDISRVLAAARMLSVVTSAVGGVYGLAAIIFSERLAAFFTDEASVLSIAGQAIVATHLPFLLFGLRQTVLILFQAQGRPNAALAVGLAQNGYLLFPLLALLPPFFGFSGLLWAMFLASALTGLLSCFCLARSLGALRQRSDEPLTSIRPYPRFCP	MKDEQLYYFEKSPVFKAMMHFSLPMMIGTLLSVIYGILNIYFIGFLEDSHMISAISLTLPVFAILMGLGNLFGVGAGTYISRLLGAKDYSKSKFVSSFSIYGGIALGLIVILVTLPFSDQIAAILGARGETLALTSNYLKVMFLSAPFVILFFILEQFARAIGAPMVSMIGMLASVGLNIILDPILIFGFDLNVVGAALGTAISNVAAALFFIIYFMKNSDVVSVNIKLAKPNKEMLSEIFKIGIPAFLMSILMGFTGLVLNLFLAHYGNFAIASYGISFRLVQFPELIIMGLCEGVVPLIAYNFMANKGRMKDVIKAVIMSIGVIFVVCMSAVFTIGHHMVGLFTTDQAIVEMATFILKVTMASLLLNGIGFLFTGMLQATGQGRGATIMAILQGAIIIPVLFIMNALFGLTGVIWSLLIAESLCALAAMLIVYLLRDRLTVDTSELIEG	104.66	gnl|BL_ORD_ID|344|hsp_num:0	377			33	1284	tigecycline
BGC0000457.1|Vicibactin_7 # 8884 # 10071 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.646	BGC0000457.1|Vicibactin_7 	8884	10071	+	Loose	400	26.1794	Erm(34)	31.94	3000600	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAACCAGTCCTTCAGCCCCCGCGACCTTGGCGCCCATGCGGCCGCCGACGATCTCTTCACCCCCGTCCATCCGGCCGCCTTCAACGCCGTCTCGCCGCCGATCTTCCAGACCTCGCTCTTTACCTATGATAGCTACGAGGCGATGGAGGATGTCTTCGCCGGCCGGACGCGCAACTTCATCTATTCGCGCGGTGACAATCCGACCGTTCGCGAATTCGAACTGCTGGTCGCCCGCCTCGAAGGCGCGGAGGATGGGCGCGCCTTTTCCAGCGGAACGGCCGCCATCACCTCGACCATTCTCAGCCTGGTGGAAGCGGGCGACCGCGTCGTTGCCGTCCGCCATCTCTATAATGACGTCTATCGCCTTCTGGTGAAGCTGCTCGGCCGGCTCGGCGTCACCGTCGATTTTGTCGATCCCTCCGACCATGACGAGGTGCGCAAGGCGCTGCCGGGCGCCAAGCTGCTCTATCTCGAAAACCCGTCTTCCTTCATCTTCGAGCTTCAGGACATCGTCGCGCTGTCGGCCATGGCGAAAGAGGCCGGCGTGACGACCATCATCGACAATAGCTGGGCGACGCCGCTTTTCCAGAAGCCGGTCCAGCATGGCGTCGATATCGTCGTCCACGCCGCCTCGAAATATCTCGGCGGCCATAGCGATACGGTCGCCGGCGTCGTCGTCGGCTCGAAGGAGGCGATCGCGAAGATCAACTCGACATCCTACCCTTATGTCGGCGCCAAGCTCGCGCCCTTCGAGGCCTGGCTGCTGCTGCGCGGCATGCGCACGCTGCGGGTGCGCCTCAAGGAGCACGAGCGCAGCGGGCTTCTGCTCGCCGATCGGCTGAAGCAGCATCCCGGCATCGCGCGTGTCCGCCACCCGGCCTTTCAGGACCATCCCGGGCGGGCGACGCTTACGGGTTATGCCGGGCTCTTCGCCTTCGACCTCACGCCCGATATCGATGTCGCGCGCTTCGTCAACGCGCTTCGCGAGATCCGCCTCGGCGTCAGCTGGGGAGGGCCGGAAACGCTGGTGGTTCCGGCCAAGGTCGCGCTGCAGATCCCCGACCGGATGACCACCTTCATCCGGTTCGGCGTGAGCGAGCAGACGATCCGTTTCGCTGTTGGGCTGGAAGAGCCGGAATTGCTGTGGAACGATTTGCAGCAGGCGCTGCACGCCGCGAAGCGGTGA	MNQSFSPRDLGAHAAADDLFTPVHPAAFNAVSPPIFQTSLFTYDSYEAMEDVFAGRTRNFIYSRGDNPTVREFELLVARLEGAEDGRAFSSGTAAITSTILSLVEAGDRVVAVRHLYNDVYRLLVKLLGRLGVTVDFVDPSDHDEVRKALPGAKLLYLENPSSFIFELQDIVALSAMAKEAGVTTIIDNSWATPLFQKPVQHGVDIVVHAASKYLGGHSDTVAGVVVGSKEAIAKINSTSYPYVGAKLAPFEAWLLLRGMRTLRVRLKEHERSGLLLADRLKQHPGIARVRHPAFQDHPGRATLTGYAGLFAFDLTPDIDVARFVNALREIRLGVSWGGPETLVVPAKVALQIPDRMTTFIRFGVSEQTIRFAVGLEEPELLWNDLQQALHAAKR	MTKKMNKYNGKKLSRGEPPNFSGQHFMHNKRLLKEIVDKADVSVRDTVLELGAGKGALTTILSERADRVLAVEYDQKCIEALQWKLVGSKNVSILHQDIMKVALPTEPFVVVSNIPYSITTAIMKMLLNNPKNKLQRGAIVMEKGAAKRFTSVSPKDAYVMAWHMWFDIHYERGISRSSFSPPPKVDSALVRIVRKQHPLFPYKEAKAMHDFLSYALNNPRAPLDQVLRGIFTAPQAKKVRQAIGVKPETPVAMLHARQWAMVCDAMVRHVPKVYWPRRKR	140.57	gnl|BL_ORD_ID|7|hsp_num:0	11			150	342	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000457.1|Vicibactin_9 # 10783 # 11274 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.638	BGC0000457.1|Vicibactin_9 	10783	11274	+	Loose	275	37.7354	AAC(6')-Ia	21.05	3002545	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGAGACGAACAGTCGAGATTCTGACCGGCAAGGCGGAGCTCTGCCGATCGATCATGGGGGCTTTGCCCGACTGGTTTTCGGAACCCGAGGTCATCGAGGCAAGCGCCCGGGCGGTCGAGGAACTGCCGGTGTTCGGATATATCGAGGCGGATGTCGTCACCGCCATGATCGCCCTGAAGCCGCACCTGCCTGATGCCGTCGAGATCGCGCTCATTGCGACCCGGCCCGAATATCACGGCCGCGGCGCCGGACGCCATCTCGTCGATGCGGCCGAACGATTCGCCCATGAATCGGGCGCCCGGCTGCTGACGGTCAAGACGCTGGCGCCGCGCGGCCGCGACGAGCCGCAATTCGAGGCGACGCGGCGCTTCTATGACCGGACCGGCTTCATCAGGGCCGAAGTCTTTGCAAAACTCTGGCATGAGGATCATCCGTGCCTGTTCATGGTCAAACCGCTCATGGAGACGCAGCTGAGCAGGACCGCGCTTTGA	MRRTVEILTGKAELCRSIMGALPDWFSEPEVIEASARAVEELPVFGYIEADVVTAMIALKPHLPDAVEIALIATRPEYHGRGAGRHLVDAAERFAHESGARLLTVKTLAPRGRDEPQFEATRRFYDRTGFIRAEVFAKLWHEDHPCLFMVKPLMETQLSRTAL	MNYQIVNIAECSNYQLEAANILTEAFNDLGNNSWPDMTSATKEVKECIESPNLCFGLLINNSLVGWIGLRPMYKETWELHPLVVRPDYQNKGIGKILLKELENRAREQGIIGIALGTDDEYYRTSLSLITITEDNIFDSIKNIKNINKHPYEFYQKNGYYIVGIIPNANGKNKPDIWMWKSLIKE	88.11	gnl|BL_ORD_ID|522|hsp_num:0	574			96	552	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
